Skip to main content
Log in

Acute Rheumatic Fever in Children

Recognition and Treatment

  • Therapy In Practice
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Acute rheumatic fever (ARF) is an inflammatory disease of the heart, joints, CNS, and subcutaneous tissue that develops after a pharyngeal infection by one of the group A β-hemolytic streptococci (Streptococcus pyogenes). The pathogenesis of the disease remains an enigma and specific treatment is not available, yet prevention of initial and recurrent attacks is possible by penicillin treatment. Rheumatic fever is especially important because of the heart disease that usually ensues; as succinctly stated by Lasegue many years ago, rheumatic fever “licks the joints and bites the heart”, a statement that holds true today. Rheumatic fever is no longer a significant health problem in most socioeconomically advanced countries but it still causes 25–40% of all cardiovascular disease in the world, including tropical countries where it was once believed to be rare. In many countries it causes more hospital admissions than congenital heart conditions.

ARF and rheumatic heart disease — with high associated morbidity, cost, and mortality — are largely preventable. Importantly, recurrences of rheumatic fever with their increased likelihood of more severe carditis are inexpensively preventable. Primary prevention has been achieved innovatively in some countries, for example, Costa Rica, and more conventionally in some developed countries. Treatment of the acute episode controls symptoms and may limit cardiac damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II
Table III
Fig. 2
Fig. 3
Table IV
Table V
Table VI
Table VII
Table VIII
Table IX
Table X
Fig. 4

Similar content being viewed by others

References

  1. Special Writing Group. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 1992; 268: 2069–73

    Article  Google Scholar 

  2. Voss LM, Wilson NJ, Neutze JM, et al. Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation 2001; 103(3): 401–6

    Article  PubMed  CAS  Google Scholar 

  3. Lennon D. Acute rheumatic fever. In: Feigin R, Cherry J, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia (PA): WB Saunders, 2004: 371–84

    Google Scholar 

  4. Steer AC, Carapetis JR, Nolan TM, et al. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002; 38: 229–34

    Article  PubMed  CAS  Google Scholar 

  5. Veasy LG, Wiedmeier SE, Ormond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316: 421–7

    Article  PubMed  CAS  Google Scholar 

  6. World Health Organization. Rheumatic fever and rheumatic heart disease. Report of a WHO Expert Consultation; 2001 Oct 29-Nov 1; Geneva

  7. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum 1995; 16: 47–51

    PubMed  Google Scholar 

  8. Vendsborg P, Fauerholdt L, Olsen KH. Decreasing incidence of a history of acute rheumatic fever in chronic rheumatic heart disease. Cardiologica 1968; 53: 332–40

    Article  CAS  Google Scholar 

  9. McNicholas A, Lennon D. Overcrowding and infectious diseases. N Z Med J 2000; 113: 453–4

    PubMed  CAS  Google Scholar 

  10. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 1973; 289: 331–5

    Article  PubMed  CAS  Google Scholar 

  11. De Cunto CL, Giannini EH, Fink CW, et al. Prognosis of children with post-streptococcal reactive arthritis. Pediatr Infect Dis J 1988; 7: 683–6

    Article  PubMed  Google Scholar 

  12. Pinals RS. Polyarthritis and fever. N Engl J Med 1994; 330: 769–74

    Article  PubMed  CAS  Google Scholar 

  13. Wilson NJ, Neutze JM. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol 1995; 50: 1–6

    Article  PubMed  CAS  Google Scholar 

  14. Ferrieri P, Jones Criteria Working Group. Proceedings of the Jones Criteria Workshop. Circulation 2002; 106: 2521–3

    Article  PubMed  Google Scholar 

  15. Abernethy M, Bass N, Sharpe N, et al. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust N Z J Med 1994; 24: 530–5

    Article  PubMed  CAS  Google Scholar 

  16. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. N Engl J Med 1961; 265: 559–66

    Article  Google Scholar 

  17. Kaplan EL, Top FH, Dudding BA, et al. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971; 123: 490–501

    Article  PubMed  CAS  Google Scholar 

  18. Martin D, Dawson K. Streptococcal serology. N Z Med J 1981; 94: 134–7

    Google Scholar 

  19. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: a paediatrician or primary care physician. Pediatr Infect Dis J 2002; 21: 420–30

    Article  PubMed  Google Scholar 

  20. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titres: normal values for children ages 2 to 12 in the United States. Pediatrics 1998; 101: 86–8

    Article  PubMed  CAS  Google Scholar 

  21. Albert DA, Hafel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995; 74: 1–12

    Article  PubMed  CAS  Google Scholar 

  22. Uziel Y, Hashkes PJ, Kassem E, et al. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr 2000; 137: 269–71

    Article  PubMed  CAS  Google Scholar 

  23. Park MK. Paediatric cardiology for practitioners. 3rd ed. St Louis (MO): Mosby Year Book, 1996

    Google Scholar 

  24. Bisno AL, Gerber MA, Gwaltney JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35: 113–25

    Article  PubMed  Google Scholar 

  25. Amir J, Ginat S, Cohen YH, et al. Lidocaine as a diluent for administration of benzathine penicillin. Pediatr Int Dis J 1998; 17: 890–3

    Article  CAS  Google Scholar 

  26. Lennon D, as member of Rheumatic Fever Working Party. Rheumatic fever secondary prophylaxis: circular letter to medical practitioners (HP 2/87). Wellington: New Zealand Department of Health, 1987

    Google Scholar 

  27. Pickering LK, Baker CJ, Overrurf GD, et al. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2003: 526–36

    Google Scholar 

  28. Lue H, Wu M, Wang J, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin prophylaxis every three weeks versus every four weeks. J Pediatr 1994; 125: 813–7

    Google Scholar 

  29. Berrios A, del Campo E, Guzman B, et al. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study. Ann Intern Med 1993; 118: 401–6

    PubMed  CAS  Google Scholar 

  30. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277: 1794–801

    Article  PubMed  CAS  Google Scholar 

  31. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever: treatment of the preceding streptococcal infection. JAMA 1950; 143: 151–3

    Article  CAS  Google Scholar 

  32. Kotloff KL, Corretti M, Palmer K, et al. Safety and immunogenicity of a recombinant multivalent Group A streptococcal vaccine in healthy adults: phase I trial. JAMA 2004; 292(6): 709

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The input of my colleagues in Auckland, New Zealand, over the years in the management of this disease is acknowledged, especially Drs Lesley Voss (Starship Children’s Hospital), Nigel Wilson (Greenlane Hospital), and Ross Nicholson (Kidsfirst, Middlemore Hospital). No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diana Lennon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lennon, D. Acute Rheumatic Fever in Children. Pediatr-Drugs 6, 363–373 (2004). https://doi.org/10.2165/00148581-200406060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200406060-00004

Keywords

Navigation